Skip to main content

Table 2 Mortality rates in male and female study participants with valid information on vital status on October 31 2015, stratified by quartiles of triglycerides, HDL cholesterol, and TG:HDL

From: Independent association of atherogenic dyslipidaemia with all‐cause mortality in individuals with type 2 diabetes and modifying effect of gender: a prospective cohort study

 

N

Events

Percent events

Events per 1000 patient-years (95% CI), unadjusted

p

Events per 1000 patient-years (95% CI), age- & gender-adjusted

p

Triglycerides

 Males

    

0.507

 

< 0.0001

  I

2219

539

24.3

33.09 (30.41–36.00)

Ref

22.71 (20.70–24.91)

Ref

  II

2224

538

24.2

32.75 (30.09–35.64)

0.865

23.36 (21.31–25.61)

0.640

  III

212

569

25.7

35.34 (32.56–38.37)

0.273

26.25 (24.01–28.69)

0.016

  IV

2247

541

24.1

32.57 (29.94–35.44)

0.796

30.15 (27.63–32.90)

< 0.0001

 Females

    

0.471

 

0.154

  I

1651

330

20.0

26.46 (23.75–29.47)

Ref

18.72 (16.65–21.05)

Ref

  II

1710

374

21.9

29.36 (26.53–32.49)

0.167

20.68 (18.49–23.12)

0.188

  III

1701

347

20.4

27.11 (24.40–30.11)

0.753

20.27 (18.11–22.70)

0.300

  IV

1692

364

21.5

28.75 (25.94–31.86)

0.274

22.25 (19.93–24.84)

0.023

HDL cholesterol

 Males

    

0.023

 

< 0.0001

  I

2038

542

26.6

36.98 (33.99–40.22)

0.210

32.14 (29.42–35.11)

< 0.0001

  II

2200

509

23.1

31.21 (28.61–34.04)

0.120

25.08 (22.88–27.49)

0.304

  III

2377

559

23.5

31.70 (29.17–34.44)

0.184

22.76 (20.79–24.91)

0.564

  IV

2287

577

25.2

34.30 (31.61–37.21)

Ref

23.55 (21.53–25.76)

Ref

 Females

    

 < 0.0001

 

< 0.0001

  I

1654

443

26.8

37.29 (33.98–40.93)

 < 0.0001

28.93 (26.12–32.05)

< 0.0001

  II

1709

322

18.8

24.79 (22.22–27.65)

0.985

18.77 (16.70–21.09)

0.136

  III

176

305

19.4

25.62 (22.90–28.67)

0.685

18.83 (16.72–21.22)

0.131

  IV

1815

345

19.0

24.82 (22.33–27.58)

Ref

16.71 (14.88–18.76)

Ref

TG:HDL

 Males

    

0.656

 

< 0.0001

  I

2223

535

24.1

32.63 (29.97–35.51)

Ref

21.62 (19.69–23.74)

Ref

  II

2228

537

24.1

32.64 (30.00–35.53)

0.992

23.38 (21.33–25.62)

0.202

  III

2226

565

25.4

34.87 (32.11–37.87)

0.270

26.80 (24.53–29.29)

< 0.0001

  IV

2225

550

24.7

33.58 (30.89–36.51)

0.633

30.80 (28.23–33.59)

< 0.0001

 Females

    

0.051

 

< 0.0001

  I

1686

325

19.3

25.31 (22.70–28.22)

Ref

17.33 (15.39–19.52)

Ref

  II

1689

347

20.5

27.33 (24.60–30.36)

0.321

19.66 (17.54–22.03)

0.103

  III

1690

354

21.0

27.98 (25.22–31.06)

0.191

20.69 (18.49–23.16)

0.022

  IV

689

389

23.0

31.15 (28.21–344.1)

0.006

24.41 (21.93–27.17)

< 0.0001

  1. TG:HDL triglyceride:HDL cholesterol ratio, CI confidence interval
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840